Organigram (OGI)
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including wh...
- Open
- 1.150
- High
- 1.320
- Low
- 1.150
- Prev. Close
- 1.230
- Volume
- 2.45M
- Turnover
- 3.05M
- Avg Price
- 1.248
- Bid/Ask Ratio
- --
- Amplitude
- 13.82%
- 52wk High
- 2.240
- Volume Ratio
- 13.47
- Turnover Ratio
- 2.59%
Organigram Analyst Rating
View moreForecast & Rating
Aug 12, 2026Price forecast
$3.26152.71%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 1 day ago, 07:06 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- PUBT · 1 day ago, 06:37 AM
Organigram Q3 FY2026 net revenue rises 49% to CAD 105.78 million, driven by Sanity Group contribution, company says
- Tip Ranks · 1 day ago, 06:05 AM
Options Volatility and Implied Earnings Moves Today, August 11, 2026
- PUBT · 1 day ago, 05:02 AM
OrganiGram Q3 FY26 net income turns to profit of $105.5 million; net revenue rises 49% to $105.8 million
- PUBT · Aug 4 at 05:01 AM
OrganiGram to report fiscal Q3 results, host conference call
- PUBT · Jul 20 at 05:03 AM
Organigram says acquired Sanity holds about 10% Germany medical cannabis market share
